Testing a Primary and a Secondary Endpoint in a Group Sequential Design
From MaRDI portal
Publication:3076047
DOI10.1111/j.1541-0420.2010.01402.xzbMath1274.62881WikidataQ34077441 ScholiaQ34077441MaRDI QIDQ3076047
Ajit C. Tamhane, Cyrus R. Mehta, Lingyun Liu
Publication date: 17 February 2011
Published in: Biometrics (Search for Journal in Brave)
Full work available at URL: http://europepmc.org/articles/pmc2925065
power; familywise error rate; multiple comparisons; multiple endpoints; O'Brien-Fleming boundary; Pocock boundary; gatekeeping procedures; secondary power
62P10: Applications of statistics to biology and medical sciences; meta analysis
62L05: Sequential statistical design
62L10: Sequential statistical analysis
Related Items
Multiple comparisons in complex clinical trial designs, Interim evaluation of efficacy or futility in group‐sequential trials with multiple co‐primary endpoints, A Note on Familywise Error Rate for a Primary and Secondary Endpoint, Sample size optimization and initial allocation of the significance levels in group sequential trials with multiple endpoints, Step-up and step-down methods for testing multiple hypotheses in sequential experiments, Sequential tests controlling generalized familywise error rates, Refined critical boundary with enhanced statistical power for non-directional two-sided tests in group sequential designs with multiple endpoints, Group-sequential logrank methods for trial designs using bivariate non-competing event-time outcomes, Comparison of design strategies for a three-arm clinical trial with time-to-event endpoint: Power, time-to-analysis, and operational aspects, Allocating recycled significance levels in group sequential procedures for multiple endpoints, A gatekeeping procedure to test a primary and a secondary endpoint in a group sequential design with multiple interim looks
Cites Work
- Discrete Sequential Boundaries for Clinical Trials
- Approximately Optimal One-Parameter Boundaries for Group Sequential Trials
- On closed testing procedures with special reference to ordered analysis of variance
- Group Sequential Tests for Bivariate Response: Interim Analyses of Clinical Trials with Both Efficacy and Safety Endpoints
- P Values Maximized Over a Confidence Set for the Nuisance Parameter
- Closed Testing Procedures for Group Sequential Clinical Trials with Multiple Endpoints
- Unnamed Item
